[ad_1]
U.S. health officials on Monday cleared the use of the first treatment for people with early-stage Covid-19 who are not hospitalized, filling a gap in treatment.
The United States Food and Drug Administration has said that the antibody drug from Eli Lilly & Co. should be used in patients aged 12 years and older with mild to moderate Covid-19, based on study showing that it has helped improve symptoms and keep many patients from being discharged from the hospital. .
The…
[ad_2]
Source link